Dr. Shannon Westin: Yeah, I think that's essential. We know that if we can sit on that prevention side and kind of invest all the time and effort that we need to upfront, that really does yield the longer survival. So why don't you just walk through the overall design of this ...
Thank you for all your support, it has meant the world to me and a special thanks to my doctors and trials nurses who have fought so hard to get me to this stage, along with the scientists who are working tirelessly in their labs, we blood cancer patients owe them a debt of gratitud...
IgG1antibody recognising the tau MTBR. E2814 and its murine precursor, 7G6, as revealed by epitope mapping, are antibodies bi-epitopic for 4R and mono-epitopic for 3R tau isoforms because they bind to sequence motif HVPGG. Functionally, both antibodies inhibited tau aggregation in vitro.They...
The extensive development, updating, and use of SOPs clearly ensure everyone is provided ample instruction on bioanalytical methods." Among the scientists within the PPD facility in Richmond, the positive sentiment was shared. As stated by Bruce Petersen, Ph.D., Senior VP Labs/Phase I, "The ...
The overall objective of this mechanistic randomized clinical trial is to use transspinal stimulation over the thoracolumbar enlargement, the spinal location of leg motor circuits, to prime locomotor training and ultimately improve the ability to stand and walk in individuals with chronic incomplete SCI...